EFPIA - NEWSLETTER

EFPIA Newsletter 30 March 2023

Blog

27 March 2023 Mission on cancer - Sustainable, science based, efficient approach toward reducing cancer burden...

The Mission’s on cancer aim is more prevention, better treatment, more lives saved, and a better quality of life for...

Strengthening European health systems

This Financial Times Digital Dialogue, held in partnership with EFPIA, will bring together policy makers and other stakeholders from across the healthcare and life sciences continuum to discuss how taking a holistic approach to healthcare spending and outcomes, and using the right policy to address the right issue can drive innovation while keeping health system sustainable and resilient for the longer term.

Stay tuned for more information and register here.

Did you miss it?

In the context of the Swedish Presidency of the Council of the European Union, this event provided a platform for dialogue and best practice sharing on how to tackle cardiovascular disease in Europe and identify key policy actions on EU and member state-level. Rewatch it here!

What we are reading

Bayer's pharma chief hopes EU takes time to improve drug rules reform 24 March 2023 (Reuters)

Call for urgency to deliver on global pledge for antibiotic incentives 30 March 2023 (ABPI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶